Mike Hsu

Mike Hsu, Chairman and CEO of Kimberly-Clark, dives into his company's strategic acquisition of Kenvue. He discusses the rationale behind the deal and outlines expected cost efficiencies. Hsu also addresses the due diligence on Tylenol's liability concerns and shares how Kimberly-Clark is preparing for potential litigation risks. The conversation further explores their brand strategy and ambitious global growth plans, showcasing how they aim to thrive in competitive markets.